Young Adult Patients With Paediatric-Onset Inflammatory Bowel Disease Have a Higher Educational Level and a Higher Employment Rate Than the General Population
- PMID: 39945233
- PMCID: PMC12269730
- DOI: 10.1002/ueg2.12772
Young Adult Patients With Paediatric-Onset Inflammatory Bowel Disease Have a Higher Educational Level and a Higher Employment Rate Than the General Population
Abstract
Background & aims: There are few published data on the impact of paediatric-onset inflammatory bowel diseases on education and employment. The objective of the present cross-sectional study was to assess the educational level and occupational status of adult patients with paediatric-onset inflammatory bowel diseases from the EPIMAD Registry.
Methods: The inclusion criteria were (i) a diagnosis of paediatric-onset (< 17 years at diagnosis) inflammatory bowel diseases, and (ii) age 25 or over at the time of study. The patients answered a self-questionnaire on their educational level and profession. The data were compared with those of the general population of the same age and geographic area.
Results: Three hundred and sixty-one patients (286 with Crohn's disease and 75 with ulcerative colitis) filled out and returned the questionnaire. The median [interquartile] age was 15.0 [12.9; 16.3] years at diagnosis and 34.2 [29.6; 39.5] years at the time of the study. Patients were more likely to have a higher education degree than the general population (57% vs. 41%, p < 0.0001). The unemployment rate was significantly lower among study participants than among the general population (9% vs. 15%, p = 0.001). Salaried patients were significantly more likely to be employed in the healthcare sector (14% vs. 9% in the general population; p = 0.005) and in the public sector (34% vs. 22% in the general population; p < 0.0001).
Conclusion: Our results showed that relative to the general population, patients with paediatric-onset inflammatory bowel diseases have a higher educational level and a higher employment rate, and are more likely to work in the healthcare and public sectors.
Keywords: Crohn's disease; education; inflammatory bowel disease; profession; ulcerative colitis.
© 2025 The Author(s). United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
Conflict of interest statement
G.S. has served as a speaker for MSD France, Ferring France, Abbvie France, and Vifor France. C.G.R. has served as a speaker for Ferring France & International, Takeda France, Tillotts France, Janssen International, and MSD France. M.F. has received lecture fees or consultancy fees from MSD, Abbvie, Takeda, Ferring, Gilead, Celgene, Celltrion, Biogen, Amgen, Fresenius, Galapagos, Tillotts, Ferring, Janssen, Hospira, Pfizer, Arena, CTMA, and Boehringer. D.L. has received lecture fees from Abbvie and Sandoz. D.T. has received lecture fees from Sandoz. H.S., M.L., and A.L. have nothing to declare.
Figures
References
-
- Duricova D., Burisch J., Jess T., Gower‐Rousseau C., and Lakatos P. L., and ECCO‐EpiCom , “Age‐Related Differences in Presentation and Course of Inflammatory Bowel Disease: An Update on the Population‐Based Literature,” J Crohns Colitis 8, no. 11 (2014): 1351–1361, 10.1016/j.crohns.2014.05.006. - DOI - PubMed
-
- Herzog D., Fournier N., Buehr P., et al., “Prevalence of Intestinal Complications in Inflammatory Bowel Disease: A Comparison Between Paediatric‐Onset and Adult‐Onset Patients,” European Journal of Gastroenterology and Hepatology 29, no. 8 (2017): 926–931, 10.1097/meg.0000000000000896. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
